Chou Y.-H.Chiang S.-C.Wei P.-F.Chen S.-S.KUAN-YIN LINCHIEN-CHING HUNG2021-08-272021-08-2720181684-1182https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057380026&doi=10.1016%2fj.jmii.2018.08.005&partnerID=40&md5=9c01c414ce036ecbdd5191d7f418d52dhttps://scholars.lib.ntu.edu.tw/handle/123456789/579813[SDGs]SDG3bilirubin; ceftriaxone; ivermectin; anthelmintic agent; abdominal radiography; adult; anemia; antibiotic therapy; antihelminthic therapy; bacteremia; bacteriuria; bilirubin blood level; blood culture; brain tomography; case report; chronic hepatitis B; clinical article; colonoscopy; computer assisted tomography; consciousness disorder; decreased appetite; descending colon; diabetes mellitus; emphysematous pyelonephritis; enterobiasis; Escherichia coli infection; feces analysis; female; fever; follow up; group B streptococcal infection; human; hyperbilirubinemia; hypertension; intestine obstruction; Letter; leukocytosis; middle aged; neutrophilia; pelvis radiography; pyuria; rectum; strongyloidiasis; thorax radiography; thrombocytopenia; treatment duration; urinalysis; urine culture; weakness; animal; colon; enterobiasis; Enterobius; feces; isolation and purification; parasitology; pathology; strongyloidiasis; treatment outcome; Animals; Anthelmintics; Colon; Enterobiasis; Enterobius; Feces; Female; Humans; Middle Aged; Strongyloidiasis; Treatment Outcomeletter10.1016/j.jmii.2018.08.005301902332-s2.0-85057380026